CD79A and cancer: Based on GO and KEGG pathway analyses, the upregulated lncRNAs that target mRNAs are mainly involved in the intermediate carbon metabolism melanoma signaling pathway in cancer (Figure 9), while the downregulated lncRNAs that target mRNAs are mainly involved in intestinal wall immune network signaling pathways for leishmaniasis and IgA products (Figure 10).